• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ACCESS BIO INCORPORATE CARESTART COVID-19 ANTIGEN HOME TEST; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ACCESS BIO INCORPORATE CARESTART COVID-19 ANTIGEN HOME TEST; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM Back to Search Results
Lot Number CP22J03
Patient Problem Insufficient Information (4580)
Event Date 12/24/2023
Event Type  malfunction  
Event Description
Test fluid did not properly absorb and migrate through test cartridge.Invalid result obtained on 3 different test cartridges.Lot: cp22j03.Reference reports: mw5149606, mw5149607.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARESTART COVID-19 ANTIGEN HOME TEST
Type of Device
CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM
Manufacturer (Section D)
ACCESS BIO INCORPORATE
MDR Report Key18409079
MDR Text Key331545393
Report NumberMW5149605
Device Sequence Number1
Product Code QKP
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 12/24/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/27/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Lot NumberCP22J03
Was Device Available for Evaluation? No
Patient Sequence Number1
Patient SexPrefer Not To Disclose
-
-